Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
tremelimumab (CP-675206) - AstraZeneca, Pfizer
lenvatinib gel suspension (AIV007) - AiViva BioPharma
https://www.eventscribe.net/2022/CIO2022/biography.asp?pfp=Speakers
Ghassan K. Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, New York
Aug 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next